G-CON Manufacturing, Inc.

This case study highlights the benefits of a pre-fabricated modular construction approach using autonomous cleanrooms in support of the accelerated delivery of a COVID vaccine manufacturing facility.

This application note provides a guideline of the steps and documentation needed to properly commission and qualify a biopharmaceutical cleanroom.

In nearly all industries, there has been a general shift away from on-site construction to prefabricated solutions. Specifically, the requirement in the biopharmaceutical industry to address speed to market and lower the total cost of ownership for facilities has accelerated this movement. More recently, the impact of COVID on our society has placed a strain on how we operate while also creating an immense need for additional capacity.